Publication:
Prognostic value of survivin expression in Wilms tumor

dc.contributor.authorBasta-Jovanovic, G. (6603093303)
dc.contributor.authorRadojevic-Skodric, Sanja (15726145200)
dc.contributor.authorBrasanac, D. (6603393153)
dc.contributor.authorDjuricic, S. (6603108728)
dc.contributor.authorMilasin, J. (6603015594)
dc.contributor.authorBogdanovic, L. (24167847400)
dc.contributor.authorOpric, D. (6506600388)
dc.contributor.authorSavin, M. (18936901400)
dc.contributor.authorBaralic, I. (24400806100)
dc.contributor.authorJovanovic, M. (56490840800)
dc.date.accessioned2025-07-02T12:40:26Z
dc.date.available2025-07-02T12:40:26Z
dc.date.issued2012
dc.description.abstractPurpose: To determine survivin expression patterns in Wilms tumor (WT) and compare it with the expression in normal renal tissue. Also, to analyse cytoplasmic and nuclear survivin expression in relation to histological type, prognostic group and tumor stage. Methods: Immunohistochemical expression of survivin was analysed in 59 cases of primary WT and in 10 normal kidney specimens, taken from the same patients, but distant from the tumor. Results: 51 out of 59 cases of WT (86.44%) showed decreased cytoplasmic survivin expression and 4 out of 59 cases of WT (6.78%) showed nuclear overexpression of survivin. There was statistically significant difference in the frequency of decreased cytoplasmic expression of survivin in individual components of WT (p=0.005). Decreased cytoplasmic expression of survivin in epithelial, blastemal and stromal component was found significantly more often in low stage WT compared to high stage WT (Fisher exact test, p=0.0002, p=0.002, p=0.002, respectively). There was no statistically significant difference in the frequency of survivin nuclear overexpression between different stages of WT (Fisher exact test, p=0.564), histological types (Fisher exact test, p=0.915), or between different prognostic groups (Fisher exact test, p=1). Conclusion: Decreased survivin cytoplasmic expression or nuclear overexpression may be related to favorable prognosis of WT. © 2012 Zerbinis Medical Publications.
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84859829280&partnerID=40&md5=f13b24ace97a1b59e3dea980fdb00344
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/13979
dc.subjectApoptosis
dc.subjectExpression
dc.subjectPrognostic value
dc.subjectSurvivin
dc.subjectWilms tumor
dc.titlePrognostic value of survivin expression in Wilms tumor
dspace.entity.typePublication

Files